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ABSTRACT 
A high sensitive voltammetric method for rapid determination of thrombin spiked in whole 
blood by taking advantage of both aptamer-based recognition and the use of a nanoporous 
membrane has been developed. The nanoporous membrane not only acts as platform for the 
thrombin recognition but also as filter of the micrometric components such as white and red 
blood cells, consequently minimizing matrix effects. The protocol involves a sandwich 
format in the inner walls (200 nm diameter) of an anodized alumina oxide filter membrane 
(AAO). The analytical signal, by DPV oxidation of [Fe(CN)6]
4- 
, is based on the blockage 
in the pores which affects the diffusion of [Fe(CN)6]
4-
 to the screen-printed carbon 
electrotransducer (SPCEs) modified with the membrane. By labeling the anti-thrombin IgG 
with AuNPs followed by silver enhancement a greater passive signal enhancement in 
comparison to the membrane blockage has been observed. The contribution of both 
electrostatic/steric effects in this blockage due to the subsequent formation of the aptamer-
thrombin complex and the final sandwich assay is investigated. The efficiency of the 
system is also monitored by microscopic techniques. The resulted biosensing system allows 
detecting thrombin spiked in whole blood at very low levels (L.O.D. 1.8 ng mL
-1
) which 
are within the range of clinical interest for the diagnostic of coagulation abnormalities as 
well as pulmonary metastasis. 
 
KEYWORDS: Nanopores; Nanochannels; Aptamer; Thrombin; Screen-printed carbon 
electrodes; Gold nanoparticles. 
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1. INTRODUCTION  
The detection of thrombin in blood is of great importance in clinical analysis. The 
thrombin-fibrinogen interaction is part of the physiological process of blood clotting and 
thrombin has also hormone-like properties when it is involved in thrombosis and platelet 
activation [Wolberg, 2007]. The concentration of thrombin in blood can vary considerably: 
it is not present in blood under normal conditions, but can reach low-micromolar 
concentrations during coagulation processes [Bichler et al., 1996]. Independently of the 
hemostatic process, thrombin circulates at the high-picomolar level in the blood of patients 
suffering from diseases known to be associated with coagulation abnormalities. 
Furthermore, thrombin is considered as a tumor marker useful for the diagnosis of 
pulmonary metastasis [Nierodzik et al., 2006]. For these both scenarios the development of 
simple (in comparison to ELISA, Western-blot, etc.) biosensing devices able to rapidly 
detect thrombin in human blood at picomolar (ng mL
-1
) levels would be of great interest.  
Colorimetric [Chen et al., 2010] and amperometric [Thuelermann et al., 2009] biosensing 
strategies that use antibodies as receptors for the detection of thrombin in blood have 
already been reported. Although the high sensitivity and low detection limits achieved 
using the mentioned approaches these still do not solve the problems related to real blood 
sample analysis also the robustness (in terms of the receptor used) while thinking for future 
in-filed / point of care applications. 
Aptamers are promising bioanalytical tools for rapid and sensitive protein detections, 
including thrombin analysis, and for developing of protein arrays [Mukhopadhay, 2005]. 
These synthetic nucleic acid sequences act as antibodies in binding proteins owing to their 
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relatively easy isolation and modification, holding a high affinity and high stability [Hansen 
et al., 2006]. It is well-known that the single-stranded DNA oligonucleotide 5’-
GGTTGGTGTGGTTGG-3’ (thrombin aptamer) acts as thrombin inhibitor. The mechanism 
of interaction consists in the binding of the aptamer to the anion-binding exosite, inhibiting 
thrombin’s function by competing with exosite binding substrates fibrinogen and the 
platelet thrombin receptor [Paborsky et al., 1993].  
This highly specific aptamer/thrombin binding interaction has been extensively approached 
to develop different biosensors for thrombin, taking advantage of the high sensitivity, 
selectivity, simple instrumentation, portability and cost effectiveness of the biosensing 
devices using different transduction techniques such as optical [Pavlov, et al., 2005], 
voltammetric [Suprun et al., 2008] and impedimetric [Zhang et al., 2009]. 
The combination of the aptamer-based electrochemical biosensors with the tools provided 
by the nanotechnology, such as the use of nanoparticle tags [Hianik et al., 2005; Heyduk et 
al., 2005] and multi-walled carbon nanotubes [Kara et al., 2010] with final detection by i.e. 
electrochemical impedance spectroscopy, has given rise to very sensitive biosensing 
systems for thrombin at even below the picomolar levels. However, in most cases a blood 
sample pre-treatment is required in order to remove red and blood cells as well as other 
components which can interfere in the specific thrombin detection. 
In this context, nanoporous materials starting from Coulter counter [Coulter, 1953] and its 
evolution from micro- to nano- sized [Bezrukov et al., 1994] sensing pores present 
outstanding new features for biosensor development [Howorka et al., 2009; Hou et al., 
2009; Martin et al., 2007]. The pioneered nanopore sensor consisted in a -hemolysin 
protein single channel embedded within a lipid bilayer membrane; an ionic current was 
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passed through the channel, and analyte species bound inside the channels were detected as 
transient blocks in this current associated with translocation of the analyte through the 
channel-stochastic sensing [Bayley et al., 2001]. The drawback related to the fragility of the 
supported bilayer membrane that houses the nanopore was then solved building artificial 
nanopores embedded in a mechanically and chemically robust synthetic membranes 
[Gyurcsányi, 2008], being the anodized alumina oxide (AAO) one of the most commonly 
used for these purposes.  
In addition to their extensive study for DNA sequencing, the blockage of the ion current in 
AAO nanochannel arrays by a bioreaction has also been approached by our group and 
others for ssDNA [Vlassiouk et al., 2005; De la Escosura Muñiz et al., 2010a] and protein 
[De la Escosura-Muñiz et al., 2010b] detection, even in blood samples [De la Escosura-
Muñiz et al., 2011], taking advantage of their properties not only as sensing platforms but 
also as filters of micrometric components of the blood. 
Here we present a novel aptamer-based biosensor for thrombin detection using AAO 
membranes, containing pores of 200 nm in diameter, and screen-printed carbon 
electrotransducers (SPCEs). The dual electrostatic/steric blockage in the pores due to the 
specific binding of thrombin and the further amplification in a sandwich assay using gold 
nanoparticle tags using the system [Fe(CN)6]
4-/3-
 as red-ox indicator is investigated. The 
nanoparticle-based amplification strategy in combination with the filtering properties of the 
membranes allows to specifically detect thrombin in whole blood at picomolar levels, 
which is within the range of clinical interest. 
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2. EXPERIMENTAL SECTION 
2.1. Apparatus and electrodes 
Anodized alumina oxide filter membranes (Whatman anodisc AAO filters, 13 mm 
diameter; 60 µm thick containing 200 and 20 nm pores of 1 x 10
9
 cm
-2
 density) were 
purchased from Scharlab (Spain). The electrochemical transducers used were homemade 
screen-printed carbon electrodes (SPCEs) and the measurements were performed using a 
home-made methacrylate cell connected to an Autolab 20 (Eco-chemie, The Netherlands). 
See the detailed SPCE fabrication procedure, pictures of the obtained sensors and of the 
electrochemical cell set-up as well as details of the optical apparatus used at the 
Supplementary material. 
2.2. Reagents and solutions 
A 5’ amino modified DNA aptamer, selective to human alpha thrombin: 5’ NH2-
GGTTGGTGTGGTTGG-3’ was purchased from Alpha DNA (Canada). Oligonucleotide 
solution was prepared in TE buffer, pH 8 (10mM Tris–HCl buffer solution, 1mM in 
EDTA) and maintained at −20 ºC. Working solutions were made in 0.1M Tris, pH 7.2 
buffer and conserved at 4 ºC.  
Thrombin from human plasma (T6884), tyrosinase (T3824) and goat anti-rabbit IgG–FITC 
(F0382) were purchased from Sigma (Spain). Human alpha thrombin and tyrosinase 
working solutions were prepared in 0.01 M phosphate buffered saline, pH 7.4 (PBS). 
Rabbit anti-human thrombin was purchased from Abcam (Spain). 
All the chemical reagents were purchased from Panreac, Sigma and Fluka (see 
Supplementary Material). 
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Lyophilised human whole blood (certified reference material, Community Bureau of 
Reference -BCR
®
 635-, preserved in sodium-EDTA anticoagulant) was purchased from 
Sigma (Spain) and reconstituted in Milli-Q water, following the manufacturer indications. 
Human Alpha Thrombin was spiked and homogenized in the resulting blood sample. 
Suspensions of AuNPs (80 nm sized) were purchased from BBInternational (UK). The 
conjugation of AuNPs to anti-human thrombin antibodies was performed according to a 
previously optimized procedure (see the Supplementary material). Zeta potential of the 
AuNPs before and after their conjugation with antibodies was determined with a Malvern 
Zetasizer Nano-ZS (Malvern Instruments Ltd., UK) according to the manufacturer’s 
recommendations. 
Silver enhancement was performed by using an LI Silver Enhancement Kit (Nanoprobes 
Inc., USA). The two components of the LI Silver Enhancement Kit were stored at 4 ° C and 
a reactive mixture was prepared at 24 ° C just before use. The stability—no self-
nucleation—is guaranteed at this temperature over 45 min. 
2.3. Methods 
Zeta Potential Measurements 
A 1 L suspension of AuNPs (the same as for the anti-thrombin/AuNPs conjugates) was 
diluted in 1 mL of PBS buffer, vortexed, and transferred into a 4 mL polystyrene cuvette 
(FB55143, Fisher Scientific). The data were collected and analyzed with the Dispersion 
Technology software 4.20 (Malvern) producing diagrams for the zeta potential as a 
distribution versus total counts. 
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AAO filter membranes functionalization and immobilization of aptamers inside the 
nanochannels 
The aptamer immobilization in the inner walls of the nanochannels was performed 
following an experimental procedure previously optimized for oligonucleotide sequences 
[De la Escosura-Muñiz et al., 2010a], consisting first in the silanization and generation of 
carbonyl groups in the walls of the nanochannels, Then the aptamer was bound through the 
peptide bond  by placing 30 µL of 1 mg mL
-1
 solution of the amino-modified aptamer on 
the filtering side of the membranes and keeping in a moist atmosphere overnight at 4ºC in 
order to avoid their dryness. To achieve such conditions, the membranes were placed in a 
glass slide inside a closed plastic box filled with water. The same experimental set-up was 
used for all the biological incubations. 
See the detailed membranes silanization procedure as well as a scheme of the full process at 
the Supplementary material. 
Aptamer/thrombin interaction inside the nanochannels 
After thorough washing in PBS buffer, 30 µL of thrombin solution was placed on the 
filtering side of the membrane and left there for 60 min at room temperature (see the 
optimization of the reaction time in the Supplementary material). 
The optimizations of the analytical method were performed using thrombin solutions in 
PBS and then the optimized method was applied for thrombin spiked in human blood.  
Blank assays were performed following the same protocol but using tyrosinase in PBS 
buffer instead of thrombin. In the case of the human blood samples analysis, the blank 
assays corresponded to the whole blood without added thrombin. 
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Sandwich assay and silver amplification 
After washing in PBS buffer, the sandwich assay was completed by placing 30 μL of the 
AuNP labeled antibody (rabbit anti-thrombin/AuNPs) on the filtering side of the 
membranes, and left there for 60 min at room temperature. After that, the membranes were 
thoroughly washed in deionized water (to avoid the further silver precipitation with 
chloride or phosphate of other anions that can be present in the sample or the buffers) and 
then 30 μL of the LI Silver Enhancement reactive mixture were placed on their filtering 
side and left there for 20 min at 24 °C, in order to selective deposit silver around the AuNPs 
tags. Finally the membranes were washed again with Milli-Q water. 
Nanoporous cell set-up and electrochemical detection 
AAO filter membranes were fixed onto the screen-printed carbon electrodes (SPCEs) by a 
physical attachment inside a methacrylate cell, as detailed at the Supplementary Material.  
The  200 L electrolytic cell defined was filled with 100 L of 1mM K3[Fe(CN)6] in 0.1M 
NaNO3 solution and a pre-treatment process at -0.55 V during 30 s was carried out in order 
to have all the Fe ions in the form of Fe (II). Immediately after, differential pulse 
voltammetry (DPV) by scanning from -0.3 V to +0.3 V (resulting in an analytical signal 
due to oxidation of [Fe(CN)6]
4-
 to [Fe(CN)6]
3-
 at approximately +0.1 V) was performed. A 
step potential of 10 mV, modulation amplitude of 50 mV and a scan rate of 33.5 mV s
-1
 
were applied during the measurements in a non-stirred solution. The measurements were 
made in ambient room air and temperature.  
Each measurement was performed with a new membrane and a new SPCE. 
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3. RESULTS AND DISCUSSION 
3.1. Label-free specific detection of thrombin: steric blockage and charge repulsion 
effects 
The label-free selective detection of thrombin using AAO nanoporous membranes is 
achieved, ascribed to the partial blockage in the diffusion of electroactive species 
([Fe(CN)6]
4-
 ions corresponding to the ferrocyanide used as red-ox indicator) through the 
nanochannels to the screen-printed carbon electrotransducer (SPCE) due to the formation of 
the complex aptamer/thrombin. This blockage gives rise to a decrease in the voltammetric 
oxidation signal of [Fe(CN)6]
4-
 to [Fe(CN)6]
3-
 chosen as analytical signal, allowing the 
detection and quantification of thrombin as schematized in Scheme 1.  
Preferred position for Scheme 1 
The reasons of the decrease in the voltammetric signal observed after the formation of the 
aptamer/thrombin complex can be attributed to a dual effect based on both steric blockage 
and charge repulsion effects. The aptamer by itself produces a certain decrease in the signal 
(Figure 1A, voltammogram b) compared with signal from the bare membranes (Figure 1A, 
voltammogran a), being this the background signal for the sensing experiments. 
Preferred position for Figure 1 
The decrease in the voltammetric signal can be explained mainly considering charge 
repulsion effects. As the oligonucleotide sequence of the aptamer is negatively charged, this 
produces a repulsion to the negative charge of the [Fe(CN)6]
4-
 ions contained in the red-ox 
indicator, being thus the ions diffusion to the electrode reduced and the later voltammetric 
re-oxidation consequently decreased. In this case, the small size of the aptamer (considering 
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the size of a 15-mer ssDNA: approximate diameter of 1.84 nm and length of 0.27 nm) 
indicates that the steric blockage in the diffusion of the [Fe(CN)6]
4- 
ions to the electrode is 
probably minimum being the charge repulsion between the redox indicator and the aptamer 
the most important factor. 
When the sample containing thrombin is added to the nanoporous membranes, the 
formation of the complex aptamer/thrombin increases both effects, allowing the thrombin 
recognition and quantification. At pH of the redox indicator medium (1mM K3[Fe(CN)6] / 
0.1M NaNO3, pH: 7.5) the thrombin is also negatively charged (the isoelectric point is 
around 7 [Schon et al., 2005]) and this charge enhances the electrostatic repulsion to the 
[Fe(CN)6]
4-
 ions, causing lower voltammetric signals (Figure 1A, voltammogram c). In 
addition, since the size of thrombin is around 4 nm [Rinker at al., 2008; Thiel, 2004], its 
presence inside the nanochannels also exerts a steric blockage considerably higher than that 
exerted by the free aptamer. This important steric contribution was evidenced by the better 
sensitivity obtained for the membranes with smaller pore sizes (20 nm) in comparison with 
the obtained for the membranes containing pores of 200 nm in diameter (LOD of around 
100 ng mL
-1
 and 10 g mL-1 respectively) as shown in Figure 1B. However, in spite of the 
better sensitivity obtained, the membranes with 20 nm sized pores were discarded since the 
very small pore size impelled unspecific blockages even by the salt crystals of the red-ox 
indicator medium. 
The specificity of the biosensing system was evaluated using tyrosinase as negative control, 
no significant changes in the analytical signal observed, evidencing that this protein is not 
neither recognized by the aptamer nor adsorbed on the inner walls of the nanochannels in a 
non-specific way (see the Supplementary material). Tyrosinase is usually used as control 
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for aptamer-based thrombin recognition assays, due to their similar size. Furthermore, 
tyrosinase has been shown to inactivate thrombin and so to modify fibrinogen [Sizer, 
1952]. In addition its presence in peripheral blood at abnormal levels has been related with 
the malignant melanoma prognosis [Carrillo et al., 2006]. 
3.2. Signal amplification using AuNPs tags and silver enhancement 
In order to improve the detection limits, an amplification strategy based on the use of 
antibodies labeled with AuNPs to complete a sandwich assay after the thrombin capturing 
by the aptamer was followed. The availability of the thrombin molecules to be recognized 
by rabbit anti-thrombin antibodies after their capture by the aptamer inside the 
nanochannels was first checked by confocal microscopy, using specific secondary anti-
rabbit antibodies labeled with a fluorescence marker (FITC). As it can be seen in Figure 
2A, fluorescence is observed not only on the surface but also inside the nanochannels, 
demonstrating the availability of the epitopes of the thrombin to be recognized by such 
antibodies. 
Preferred position for Figure 2 
The amplification of the analytical signal (decrease in the voltammetric peak current) was 
then accomplished performing the sandwich assay with AuNPs (80 nm sized) labels (figure 
1A, voltammogram d), allowing to improve the LOD of thrombin from 10 g mL-1 to 
around 10 ng mL
-1
 (figure 1B). 
The explanation of such LOD improvements of  around three orders of magnitude more 
sensitive than for the label-free assay can be found again in the combination of 
electrostatic/steric blockage in the diffusion of the [Fe(CN)6]
4-
 ions through the nanopores 
to reach the electrode. The large size of the AuNPs (80 nm) increases in a high extent the 
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physical blockage of the diffusion of the electroactive ions to the electrode. In order to 
elucidate the electrostatic contribution to this blockage it was taken advantage of the zeta 
potential technique. Zeta potential technique has been recently reported as an efficient tool 
which allows the monitoring and analysis of chemical modifications on the surface of 
nanoparticles, with minimal sample preparation [Thielbeer et al., 2011]. The zeta potential 
is generated when charged particles are dispersed in a medium and gives rise to the 
formation of an electric potential between the surface of the particle and the medium, 
because the surface charge of the particle attracts counterions. A double layer is formed at 
the interface of the particle; the first layer (so called Stern-layer) contains ions directly 
adsorbed to the surface, and this layer is surrounded by a more diffuse second layer of 
mobile ions attracted by the surface charge. The potential between the diffuse layer and the 
medium is called the zeta potential. The easily measurable zeta potential (in contrast with 
the extreme difficulty to measure the potential of the Stern-Layer) has consequently been 
used to obtain information concerning the particle surface charge, chemical modifications 
and also stability of colloid suspensions [Butt et al., 2003]. A high zeta potential (positive 
or negative) confers stability since the solution or dispersion resists aggregation. When the 
absolute value of the zeta potential is low, attraction exceeds repulsion and the dispersion 
breaks and flocculates. Due to all that, it has been defined that nanoparticle suspensions 
begin to be moderated stable for absolute zeta potential values higher than 10 mV. So both 
unmodified AuNPs and anti-thrombin/AuNPs were analyzed by zeta potential, following 
the experimental procedure detailed in materials and methods section. As can be observed 
in the graph of figure 2B, the value of the zeta potential of the AuNP suspensions was 
around -30 mV, indicating a very negative surface charge and a good stability. This 
negative charge is probably due to the citrate ions (used as reductive agents in the AuNPs 
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synthesis) which are recovering and stabilizing the AuNPs. After the conjugation with the 
antibody, this value shifted to -17 mV evidencing the probable substitution of the citrate 
ions on the surface of the AuNPs by the antibodies, giving rise to negative charged 
conjugates which are still within the stability range of values. 
Consequently, when the sandwich assay is performed with the anti-thrombin/AuNPs 
conjugate, the negative charge of the conjugate is added to that of the thrombin, increasing 
the electrostatic repulsion of the [Fe(CN)6]
4-
 ions as schematized in the cartoon of Figure 
2B. 
Finally, the catalytic activity of the AuNPs on the silver reduction was also approached to 
selectively deposit silver around the AuNPs, forming a shell that grows up reaching 
approximately the same size of the nanochannel’s diameter (200 nm). As indicated by 
Figure 3 (right), silver enhanced AuNPs perfectly fit inside the channels allowing a highly 
enhanced steric blockage to the diffusion of the [Fe(CN)6]
4-
 ions.  
Preferred position for Figure 3 
The voltammetric peak currents in the presence of silver enhanced AuNPs are the lowest 
registered (Figure 1A, voltammogram e) evidencing the predominance of the highly 
enhanced steric blockage in this case. It is also noticed the presence of a peak 
corresponding to the re-oxidation of the deposited Ag
0
 to Ag
+
 at around 0.0 V which does 
not affect the peak at approximately +0.1 V and that is not considered for analytical 
purposes. This strategy allows detecting up to around 1 ng mL
-1
 of thrombin (Figure 1B). 
The value meets the range of clinical interest. 
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3.3. Thrombin analysis in human blood 
As it has been mentioned, the detection of thrombin in whole human blood is of great 
importance in clinical analysis, not only for the diagnosis of coagulation problems also for 
its consideration as a tumor marker. As it has been recently reported by our group, one of 
the main advantages of the use of nanoporous membranes as biosensing platforms consists 
in their ability to act also as filter of biomolecules with sizes larger than the pore diameter 
[De la Escosura-Muñiz et al., 2011]. This filter-like effect minimizes matrix effects upon 
the analytical signal and allows the direct detection of proteins in blood, without any pre-
treatment of the sample (centrifugation/re-suspension processes, etc.). 
Considering that, human blood solutions were spiked with thrombin (see materials and 
methods section) and the same experimental procedure as the one followed for the solutions 
prepared in buffer was carried out. The predicted filtering effect of the nanoporous 
membranes was first evidenced by SEM analysis. As it can be clearly seen in Figure 4, the 
white and red blood cells do not enter into the membranes because of the size-exclusion 
effect, while most of the pores remain free.  
Preferred position for Figure 4 
Thrombin can penetrate through these pores, being captured inside the nanochannels by the 
aptamer. It is important to highlight that the optimized aptamer/thrombin reaction time (60 
min) is low enough to guarantee that, thanks to the chelate effect of the EDTA 
anticoagulant, the Ca
2+
 ions in blood remain complexed and are not able to exert their effect 
in the prothrombin conversion to thrombin [Mitchell, 2009]. Reaction times longer than 2 
hours would give rise to the starting of the coagulation process (even in the presence of the 
anticoagulant) and the presence of no thrombin added (note also that due to the special 
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conditions of the sample preparation for the SEM analysis, the observed sample 
characteristics are not the same as for the electrochemical measurements). 
The thorough washing of the membrane (after incubations with 30 L of whole blood with 
spiked thrombin) allows removing of the cells and continuing of the later incubation with 
AuNPs labeled antibodies and the silver enhancement without matrix interferences. The 
selective formation of the silver shells inside the nanochannels was clearly observed too by 
SEM (Figure 3, right). When the assay is performed for blood without added thrombin, 
silver crystals are not observed (Figure 3, left) demonstrating the specificity of the assay as 
well as of this amplification strategy. 
Furthermore, it must be highlighted that the quantity of silver shells observed along the 
nanochannels is much higher than the observed, i.e. in previous works for sandwich 
immunoassays using both capturing and signaling antibodies [De la Escosura-Muñiz et al., 
2011]. This can be due to the fact that in the case of the sandwich immunoassays, after the 
recognition by the capturing antibody the number of the epitopes available in the antigen 
for the later recognition by the signaling antibody is limited; a competition between both 
antibodies (capturing and signaling antibodies) for the epitopes (being this more critical for 
small proteins) occurs. However, in the case of the aptamer based assays, the aptamer-
protein interaction doesn’t affect the protein epitopes, keeping these more available for the 
later interaction with the signaling antibody [He et al., 2007; Kang et al., 2008]. This gives 
rise to the presence of a higher quantity of labeled antibodies for each thrombin molecule as 
observed through the high abundance of silver crystals in the inner walls of the 
nanochannels. 
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These optical observations are in correlation with the electrochemical results. As it can be 
observed in Figure 5A, the voltammetric peak currents registered at approximately +0.1 V 
corresponding to the oxidation of [Fe(CN)6]
4-
 to [Fe(CN)6]
3-
 decrease when the thrombin 
concentration in blood increases. 
Preferred position for Figure 5 
 It is also noticed that the peak corresponding to the re-oxidation of the deposited Ag
0
 to 
Ag
+
 at around 0.0 V is always present but does not affect the analytical peak at +0.1 V. The 
presence of this silver-related peak and its current intensity corroborates the explanations 
given for the sensing principle using enhancement method. For the highest concentration of 
thrombin in blood, the Ag
0
 re-oxidation peak reaches a maximum value due to the 
formation of a higher number of silver crystals inside the channels. In contrast, for the 
lowest concentration of thrombin, the small quantity of silver crystals gives rise to the 
lowest peak current intensity. However, the irreproducibility observed for the intermediate 
thrombin concentrations (probably due to the different distances between the silver crystals 
and the electrode surface for the different membranes and electrodes) does not allow to 
consider this peak for analytical purposes. When the assay is performed for a blood sample 
without thrombin, the silver peak is not observed (Figure 5A, dashed line) and the value of 
the peak current at +0.1 V is only a little bit lower than the background signal defined in 
previous sections (signal corresponding to obtained for the membranes with only aptamer), 
indicating a minimum unspecific absorption of some of the blood proteins (albumins, 
globulins and fibrinogen, all of them presented at grams per liter levels) in the inner walls 
of the membranes. 
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As it can be observed in Figure 5B, there is a linear relationship between the analytical 
voltammetric peak current at +0.1 V and the thrombin concentration in the range of 2-100 
ng mL
-1
, with a correlation coefficient of 0.997, adjusted to the following equation:  
peak current (A) = -0.003 [thrombin (ng mL-1)] + 0.4 (n = 3) 
The reproducibility responses of 60 ng mL
-1
 thrombin, n = 10, give a relative standard 
deviation (RSD) of 8% and the limit of detection calculated as the concentration of 
thrombin corresponding to three times the standard deviation of the estimate was 1.8 ng 
mL
-1
. This value, as well as the linear response range, are comparable and even better than 
those obtained with other aptamer-based optical [Chen et al., 2010] and electrochemical [Li 
et al., 2010] biosensors for the detection of thrombin in whole blood within the above 
mentioned range of clinical interest, opening the way to future applications in diagnostics. 
 
4. CONCLUSIONS 
A simple aptamer modified nanochannel for thrombin detection in whole blood is 
presented. It is based on electrochemical detection using DPV of [Fe(CN)6]
4-
 / [Fe(CN)6]
3-
 
system used as indicator. The detection principle and the effect of the electrostatic 
interactions between thrombin and the aptamer modified inner walls of the nanochannel 
including the steric effects (thrombin aptamer, thrombin, nanoparticle and nanochannel 
sizes) are also clarified.  
The developed nanochannels/aptamer based sensing system is applied for the direct 
detection of thrombin spiked in a whole blood sample. The efficiency of the nanoporous 
platform to act as a filtering layer avoiding the possible interferences of the sample matrix 
such as the red and white blood cells beside other micro components is checked through 
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SEM observations beside electrochemical signals. The efficiency of the thrombin aptamer 
to selectively detect thrombin even in the presence of the high concentrations of  blood 
proteins (albumins, globulins and fibrinogen, all them present at grams per liter levels) was 
also demonstrated. Furthermore, it is previewed an improvement in the performance of the 
biosensing system by tunning the thickness of the membranes as well as the pores density 
and diameter, bringing advantages such as lower protein detection limits. 
The developed platform is previewed to bring advantages in several other proteins 
detections from complex matrix/samples. The high stability / robustness, selectivity and 
sensitivity of aptamers combined with the simplicity of nanochannels based platform may 
bring novel interesting applications for several other diagnostics, safety and security 
applications.  
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FIGURE CAPTIONS 
Scheme 1. Scheme of the sensing principle. The presence of thrombin in the sample 
(middle) difficult the diffusion of the [Fe(CN)6]
4-
 ions through the nanoporous membranes 
to the electrode, due to both steric/electrostatic effects in comparison with the sample 
without thrombin (left), resulting in a decrease in the voltammetric signal of the [Fe(CN)6]
4-
 
/ [Fe(CN)6]
3-
 system. Both effects are enhanced doing a sandwich assay with AuNP labeled 
antibodies and the steric effect is highly increased depositing silver around the AuNPs 
(right). 
Fig. 1. (A) DPVs registered in 1mM K3[Fe(CN)6] / 0.1M NaNO3 for the SPCE covered 
with unmodified AAO filter membranes of 200 nm pore size (a) and for membranes 
modified with the aptamer before (b) and after (c) the reaction with 20 g mL-1 of thrombin 
in PBS buffer (label-free assay); and after the reaction with 50 ng mL
-1
 of thrombin in PBS 
and sandwich assays performed with anti-thrombin/AuNPs (d) and after the silver 
enhancement (e). DPV parameters: pre-concentration potential: –0.3 V; pre-concentration 
time: 30 s; step potential: 10 mV; modulation amplitude: 50 mV; scan rate: 33.5 mV s
-1
. 
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(B) Comparison of the limits of detection of thrombin obtained for the label-free assay for 
both membranes of 200 nm and 20 nm pore sizes and for the sandwich assays performed 
with AuNPs tags for the membranes of 200 nm pore sizes without and with silver 
enhancement. 
Fig. 2 (A) Confocal microscopy images of an AAO filter membrane of 200 nm pore size 
after the aptamer modification, reaction with thrombin, sandwich assay with rabbit anti-
thrombin antibodies and secondary reaction with anti-rabbit antibodies labeled with FITC. 
Plan view (a) and planes until 2 μm in depth from the top surface (b,c) and from the bottom 
surface (b′,c′). (B) (Up) Diagram for the zeta potential as a distribution versus total counts 
for a dispersion of AuNPs before and after the conjugation with anti-thrombin IgG and a 
dispersion of the conjugate anti-thrombin/AuNPs; (Down) Schematic of the enhancement 
in the electrostatic repulsion to the [Fe(CN)6]
4-
 ions diffusion into the nanochannels due to 
the negatively charged AuNPs tags in a sandwich assay. 
Fig. 3. SEM (cross-sectional view) images of AAO filter membranes of 200 nm pore size 
modified with the aptamer and left to react with a blood sample containing 100 ng mL
-1
 of 
spiked thrombin (Right) and a blood sample without spiked thrombin (Left). The sandwich 
assay is then completed with anti-thrombin/AuNPs followed by silver enhancement (white 
silver crystals are observed). Inset cartoons correspond to schemes of the involved 
processes. 
Fig. 4. SEM (top view) images of different zones of an AAO filter membrane of 200 nm 
pore size on which a 30 μL drop of blood was deposited and treated following the 
procedure detailed in the materials and sections method. White and red blood cells as well 
as the nanopores are observed. (Note that these images are representative of what happens, 
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although the morphology of the cells is altered due to the sample treatment necessary for 
the SEM analysis). 
Fig. 5. (A) DPVs registered 1mM K3[Fe(CN)6] / 0.1M NaNO3 following the optimized 
experimental procedure for blood samples containing spiked thrombin at concentrations of 
(up to down): 0 (dashed line), 2, 20, 60, 80 and 100 ng mL
-1
. DPV parameters are the same 
as those in figure 1A. (B) Effect of the concentration of thrombin spiked in blood on the 
voltammetric peak current of oxidation of [Fe(CN)6]
4-
 to [Fe(CN)6]
3- 
(approx. +0.1 V) 
chosen as analytical signal. 
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Chemicals  
Potassium hexacyanoferrate (K3[Fe(CN)6]), glutaraldehyde solution 25% and acetone were 
purchased from Panreac (Spain). Sodium nitrate (NaNO3) was purchased from Sigma 
(Spain), 3-amino-propiltrimethoxysilane (APS) and propylamine were provided by Fluka 
(Spain). All reagents were of analytical reagent grade and used without further purification 
and all the aqueous solutions were prepared in Milli-Q water.  
Optical apparatus  
Optical characterizations of the AAO filter membranes were performed using a scanning 
electron microscope -SEM- (Zeiss EVO® MA 10, Carl Zeiss Microscopy, International 
Germany) and a Confocal Laser Microscope (TCS SP2 AOBS, Leica, Germany).  
Fabrication of screen-printed carbon electrodes (SPCEs) 
The electrochemical transducers used were homemade screen-printed carbon electrodes 
(SPCEs), consisting of three electrodes: working electrode, reference electrode and counter 
electrode in a single strip fabricated with a semi-automatic screen-printing machine 
DEK248 (DEK International, Switzerland). The reagents used for this process were: 
Autostat HT5 polyester sheet (McDermid Autotype, UK) and Electrodag 423SS carbon ink, 
Electrodag 6037SS silver/silver chloride ink and Minico 7000 Blue insulating ink (Acheson 
Industries, The Netherlands). The full size of the sensor strip was 29mm x 6.7mm, and the 
WE diameter was 3mm. The fabrication of the SPCEs was carried out in three steps. First, a 
graphite layer was printed onto the polyester sheet, using the screen-printing machine with 
the stencil (where it is the electron pattern). After curing for 15 minutes at 95ºC, an 
Ag/AgCl layer was printed and cured for 15 minutes at 95ºC. Finally, the insulating ink 
was printed and cured at 95ºC for 20 minutes. 
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Figure S1 shows images of the 45-sensor sheet obtained following the detailed 
experimental procedure. 
 
AAO membranes silanization and generation of carbonyl groups 
AAO filter membranes were boiled in Milli-Q water for 1h, dried in Argon and then 
immersed into a 5% APS solution in acetone for 1 h. After thorough washing in acetone 
and baking at 120ºC for 30 min, the membranes were left overnight in 25% aqueous 
solution of glutaraldehyde, followed by washing in Milli-Q water. See a scheme of the 
experimental procedure in figure S5. 
Finally, after the aptamer immobilization (detailed in the main manuscript text) the 
glutaraldehyde was neutralized overnight in 10
-5
M aqueous solution of propylamin, in order 
to improve the further aptamer recognition efficiency. 
Conjugation of AuNPs to anti-thrombin IgG antibodies 
The conjugation of AuNPs to anti-thrombin antibodies was performed according to the 
following procedure [; De la Escosura-Muñiz et al. Biosen. Bioelectron. 24 (2009) 2475–
2482]. The amount of antibodies necessary to obtain the total coverage of the AuNPs was 
optimized through the gold aggregation test [A. Ambrosi et al. Anal. Chem. 79 (2007) 
5232-5240]. 
AuNP suspension (2 mL) was mixed with the antibody solution (100 μL, 100 μg mL-1) and 
incubated at 25° C for 20 min. Subsequently, a blocking step with bovine serum albumin 
(BSA; 150 μL, 1 mg mL-1) by incubating at 25 ° C for 20 min was undertaken. Finally, 
centrifugation at 4 ° C and 14 000 rpm for 20 min was carried out, and anti-thrombin 
IgG/AuNPs conjugates were reconstituted in PBS solution. 
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Optimization of the aptamer/thrombin interaction time 
The aptamer/thrombin interaction time was optimized for the 200 nm pore sized 
membranes in the label-free assay, fixing a concentration of thrombin of 100 g mL-1 and 
keeping the rest of the experimental conditions detailed in the materials and methods 
section of the main text. The values of the voltammetric peak current at +0.10 V (analytical 
signal) registered for incubation times of 10, 20, 30, 45, 60 and 90 minutes are shown in 
figure S2. As it can be observed, when higher is the incubation time higher is the analytical 
signal reaching a plateau at 60 minutes. This time was consequently chosen as optimum for 
the experimental procedure. 
 
Sample preparation for SEM analysis 
30 L of the blood sample were placed on the filtering side of the AAO filter membranes 
and left in a petri dish for 60 minutes. After that, the membranes were immersed in 2.5 % 
glutaraldehyde in order to fix the cells there overnight. After that, the samples were 
dehydrated sequentially in ethanol of different purities (1X 50º, 2X 70 º, 3X 90º, 3X 95º, all 
these steps consisted in immersion during 10 minutes; 3X 100º, these steps were perfomed 
during 20 minutes). After that, the membranes were immersed in etanol/HMDS for 20 
minutes and finally in HMDS 100º (2X, 30 minutes). The excess of HMDS was removed 
and then the membranes were coated by an sputtering of gold and then analyzed in the 
SEM.  
 
 
35 
 
Electrochemical cell set-up 
AAO filter membranes were fixed onto the screen-printed carbon electrodes (SPCEs) by a 
physical attachment inside a methacrylate cell, achieved by placing the SPCE onto a 
methacrylate block and putting the membrane with the filtering side up covering in this way 
the three electrodes surface. Then, a second methacrylate block containing a hole of the 
same size as the working area of the SPCE was placed onto the membrane, using an 
insulating O-ring between them to avoid liquid leakage and finally the system is fixed using 
screws. In this way, a  200 L electrolytic cell is defined (see figure S3).  
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Figure S1. (Left) Images of the 45 SPCE sensors sheet obtained following the detailed 
experimental procedure. (Right) Detail of one SPCE, containing the three electrodes in the 
working area: R- Ag/AgCl reference electrode, W- carbon working electrode and C- carbon 
counter electrode. 
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Figure S2. Effect of the aptamer/thrombin incubation time on the voltammetric peak 
current chosen as analytical signal. Thrombin concentration: 100 g mL-1. Label-free assay. 
Membranes pore size: 200 nm. The rest of the experimental conditions are the detailed in 
the materials and methods section of the main text. 
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Figure S3. (Left) Picture of the SPCE placed into the two methacrylate blocks with the 
AAO filter membrane covering the working area. (Right) Cell assembled, filled with 1mM 
K3[Fe(CN)6]/0.1M NaNO3 solution and connected to the potentiostat. 
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Figure S4. TEM image obtained for the AuNPs used as tags (above) and the corresponding 
size distribution (below). 
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Figure S5. . Schematic representation of the processes involved for the nanochannels 
functionalization, immobilization of the aptamer, reaction with thrombin and 
electrochemical measurement: (I) generation of amino groups on internal walls by 
silanization reaction with 3-amino propiltrimethoxysilane (APS); (II) generation of 
carboxyl groups by reaction with glutaraldehyde; (III) immobilization of aptamer by petide 
bond; (IV) reaction with aptamer. 
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Figure S6. (A) Scheme of the process which occurs inside the nanochannels and the 
corresponding DPVs obtained in 1 mM K3[Fe(CN)6]/0.1 M NaNO3 for AAO filter 
membranes with 200 nm pore sizes after the aptamer immobilization (a) the reaction with 1 
mg ml
-1
 of tyrosinase (b) and the reaction with the same concentration of thrombin (c). (B) 
Summary of the obtained results. 
 
